...
首页> 外文期刊>American journal of lifestyle medicine >Prevalence of Medication Use in Children for Cardiometabolic Risk Reduction
【24h】

Prevalence of Medication Use in Children for Cardiometabolic Risk Reduction

机译:小儿使用药物治疗可降低心脏代谢风险

获取原文
获取原文并翻译 | 示例

摘要

Abstract: Recently there has been concern regarding the prevalence of medication use in children to manage the same cardiometabolic risk factors that traditionally begin in adulthood, but are now more prevalent in children. Two studies have been published reporting the actual prevalence of medication use in children to treat the conditions of high blood pressure, high cholesterol, and diabetes. Both studies report that the overall prevalence of medication use among children to manage these conditions is increasing. Concurrently, physical activity levels and healthy eating habits in children are decreasing and the incidence of obesity is increasing. Although medications used to treat cardiometabolic risks are important for preventing future cardiovascular disease, greater resources should be dedicated toward lifestyle medicine-related treatment and prevention efforts in this population to improve the future health of these individuals and the general health of America.
机译:摘要:最近,人们开始关注儿童中使用药物来控制与成人相同的心脏代谢危险因素的普遍性,但现在在儿童中更为普遍。已经发表了两项研究,报告了儿童治疗高血压,高胆固醇和糖尿病的实际使用率。两项研究均报告说,在儿童中使用药物治疗这些疾病的总体患病率正在上升。同时,儿童的体育活动水平和健康饮食习惯正在下降,肥胖的发生率也在增加。尽管用于治疗心脏代谢风险的药物对于预防未来的心血管疾病很重要,但应在此人群中投入更多资源用于与生活方式医学相关的治疗和预防工作,以改善这些人的未来健康状况和美国的整体健康状况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号